Dr. Ansell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1996 - 1999
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1994 - 1996
- University of Pretoria Faculty of MedicineClass of 1986
Certifications & Licensure
- AZ State Medical License 1998 - 2025
- MN State Medical License 1996 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1999 Oct 01
- Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2001 Oct 01
- CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma Start of enrollment: 2002 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy.Jessica F Burlile, Kelsey M Frechette, William G Breen, Steven R Hwang, Alexandra S Higgins, Adrienne N Nedved, William S Harmsen, Sydney D Pulsipher, Thomas E Witzig,...> ;Blood Advances. 2024 Mar 12
- Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.Jordan E Krull, Kerstin Wenzl, Melissa A Hopper, Michelle K Manske, Vivekananda Sarangi, Matthew J Maurer, Melissa C Larson, Patrizia Mondello, ZhiZhang Yang, Joseph P...> ;Cell Reports. Medicine. 2024 Mar 19
- Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy.Radhika Bansal, Paschalis Vergidis, Pritish K Tosh, John Wilson, Matthew Hathcock, Arushi Khurana, N Nora Bennani, Jonas Paludo, Jose C Villasboas, Yucai Wang, Stephen...> ;Transplantation and Cellular Therapy. 2024 Apr 1
- Join now to see all
Journal Articles
- Primary Systemic Amyloidosis in Patients with Waldenström MacroglobulinemiaAngela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
- Targeting CD38 with Daratumumab Is Lethal to Waldenström Macroglobulinaemia CellsRichard Furman, Stephen M Ansell, Sikander Ailawadhi, Thomas E Witzig, Vivek Roy, Taimur Sher, Liuyan Jiang, British Journal of Haematology
Abstracts/Posters
- Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for LymphomaStephen M. Ansell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long Non-Coding RNA Expression in Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined SignificanceStephen M. Ansell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade LymphomasStephen M. Ansell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Bridging the Translational Divide: The Role of the PhD61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Older Patients (pts) with Previously Untreated Classical Hodgkin Lymphoma (cHL): A Detailed Analysis from the Phase 3 ECHELON-1 Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Practice Changing: Ibrutinib in Front-line MCLDecember 11th, 2022
- Cancer Death Rates Continue to Fall, Researchers ReportSeptember 22nd, 2022
- ECHELON-1 Trial: Brentuximab Vedotin with Chemotherapy Offers Survival Benefit in Stage III or IV Hodgkin LymphomaJuly 26th, 2022
- Join now to see all
Grant Support
- P4 - Regulatory T-Cells In The Tumor Microenvironment Of B-Cell Non-HodgkinNational Cancer Institute2010–2011
- Biologic Therapy For B-Cell Non-Hodgkin'S LymphomaNational Cancer Institute2008–2011
- Regulatory T-Cells In The Tumor Microenvironment Of B-Cell Non-HodgkinNational Cancer Institute2007–2009
- Blys Inhibition Using Taci-Fc In Patients With B-Bell Non-Hodgkins'LymphomaNational Cancer Institute2007–2008
- Intra-Tumoral Injection Of Measles Virus Vaccine In Patients With Relapsed B-CelNational Center For Research Resources2005
- Biologic Therapy For Beta-Cell Non-Hodgkin'S LymphomaNational Cancer Institute2004–2005
- Biologic Therapy For Beta-Cell Non-Hodgkin'S LymphomaNational Cancer Institute2002–2003
Professional Memberships
- Member
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: